lx1033
Small moleculeexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 2011 (NCT01411800)
Timeline
Indications
Studied for
Mechanism of action
- Tryptophan 5-hydroxylase 2INHIBITOR
TPH2 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- lx1033
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01494233 | Phase 2 | Feb 1, 2012 | Lexicon Pharmaceuticals |
| NCT01411800 | Phase 1 | Aug 1, 2011 | Lexicon Pharmaceuticals |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Lexicon Pharmaceuticals | For profit | 2 | 2 | 2 | 2011 |
1 organizations
Page 1 / 1